We obtained our sporadic thyroid cancer mouse model TgCreERT2;BrafCA/+ by crossing the established BrafCA and TgCreERT2 mouse lines (Dankort et al., 2007; Undeutsch et al., 2014) to conditionally express BRAFV600E in the thyroid under control of the thyroglobulin (Tg) promoter, as previously reported (Charles et al., 2011). This evidence concerns the gene TG and thyroid cancer.